Viral genotypes and associated risk factors of hepatocellular carcinoma in India

Cancer Biology and Medicine

Volumn 9, Issue 3, 2012, Pages 172-181

  Sarma, M P ^a   Asim, Mohammad ^a   Medhi, Subhash ^a   Bharathi, Thayumanavan ^b   Diwan, Richa ^a   Kar, Premashis ^a  

^a MAULANA AZAD MEDICAL COLLEGE   (India)

^b Government Rajaji Hospital   (India)

Author keywords

Hepatitis B virus; Hepatitis C virus; Hepatocellular carcinoma; Risk factors

Indexed keywords

RNA;

ADOLESCENT; ADULT; AGED; ALCOHOL CONSUMPTION; ARTICLE; BLOOD SAMPLING; CANCER RISK; CHILD; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; INDIA; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCHOOL CHILD; VIRUS GENE; VIRUS LOAD;

EID: 84876318697     PISSN: 20953941     EISSN: None     Source Type: Journal    
DOI: 10.7497/j.issn.2095-3941.2012.03.004     Document Type: Article

References (54)

1. Perz JF, Armstrong GL, Farrington LA, et al. The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide. J Hepatol 2006; 45: 529-538.
2. Mori M, Hara M, Wada I, et al. Prospective study of hepatitis B and C viral infections, cigarette smoking, alcohol consumption, and other factors associated with hepatocellular carcinoma risk in Japan. Am J Epidemiol 2000; 151: 131-139.
3. Oyunsuren T, Kurbanov F, Tanaka Y, et al. High frequency of hepatocellular carcinoma in Mongolia; association with mono-, or co-infection with hepatitis C, B, and delta viruses. J Med Virol 2006; 78: 1688-1695.
4. Kumar M, Kumar R, Hissar SS, et al. Risk factors analysis for hepatocellular carcinoma in patients with and without cirrhosis: A casecontrol study of 213 hepatocellular carcinoma patients from India. J Gastroenterol Hepatol 2007; 22: 1104-1111.
5. Levrero M. Viral hepatitis and liver cancer: The case of hepatitis C. Oncogene 2006; 25: 3834-3847.
6. El-Serag HB, Tran T, Everhart JE. Diabetes increases the risk of chronic liver disease and hepatocellular carcinoma. Gastroenterology 2004; 126: 460-468.
7. Chen CH, Huang GT, Yang PM, et al. Carcinomas yield different clinical features and prognosis. Eur J Cancer 2006; 42: 2524-2529.
8. Merle P. Epidemiology, natural history and pathogenesis of hepatocellular carcinoma. Cancer Radiother 2005; 9: 452-457.
9. Amarapurkar DN, Patel ND, Kamani PM. Impact of diabetes mellitus on outcome of HCC. Ann Hepatol 2008; 7: 148-151.
10. National Cancer Registry Programme. Annual Report 1987. New Delhi: Indian Council of Medical Research, 1990.
11. Jayant K, Rao RS, Nene BM, et al. Rural Cancer Registry at Barshi: Report 1988-92. Barshi: Rural Cancer Registry 1994.
12. Idilman R, De Maria N, Colantoni A, et al. Pathogenesis of hepatitis B and C-induced hepatocellular carcinoma. J Viral Hepat 1998; 5: 285-299.
13. De Mitri MS, Poussin K, Baccarini P, et al. HCV-associated liver cancer without cirrhosis. Lancet 1995; 345: 413-415.
14. London WT, McGlynn KA. Liver cancer. In: Schottenfeld D, Fraumeni JF Jr, eds. Cancer Epidemiology and Prevention. New York: Oxford University Press 1996; 772-793.
15. Bruix J, Sherman M, L lovet JM, et al. Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. J Hepatol 2001; 35: 421-423.
16. Leevy CM, Sherlock S, Tygstrup N, et al. (Eds) Diseases of the Liver and Biliary Tract. Standardization of Nomenclature, Diagnostic Criteria and Prognosis. New York: Raven Press 1994; 61-62.
17. Chinchai T, Labout J, Noppornpanth S, et al. Comparative study of different methods to genotype hepatitis C virus type 6 variants. J Virol Methods 2003; 109: 195-201.
18. Sarin SK, Thakur V, Guptan RC, et al. Profile of hepatocellular carcinoma in India: An insight into the possible etiologic associations. J Gastroenterol Hepatol 2001; 16: 666-673.
19. Singh SV, Goyal SK, Chowdhury BL. Primary carcinoma of liver in Udaipur. J Assoc Physicians India 1971; 19: 693-695.
20. Feitelson MA, Duan LX. Hepatitis B virus antigen in the pathogenesis of chronic infections and the development of hepatocellular carcinoma. Am J Pathol 1997; 150: 1141-1157.
21. Takano S, Yokosuka O, Imazeki F, et al. Incidence of hepatocellular carcinoma in hepatitis B and C: A prospective study of 251 patients. Hepatology 1995; 21: 650-655.
22. Tsukuma H, Hiyama T, Tanaka S, et al. Risk factors for hepatocellular carcinoma among patients with chronic liver disease. N Engl J Med 1993; 328: 1797-1801.
23. Okuda K, Kojiro M, Okuda H. Neoplasms of the liver. In: Schiff L, Schiff ER, eds. Diseases of the Liver. Philadelphia, J. B. Lippincott Company 1993: 1236-96.
24. Oka H, Kurioka N, Kim K, et al. Prospective study of early detection of hepatocellular carcinoma in patients with cirrhosis. Hepatology 1990; 12: 680-687.
25. Pyrsopoulos N, Reddy RK. Hepatocellular carcinoma in Asia. In: Sarin SK, Okuda K, eds. Hepatitis B and C. Carrier to Cancer. India, Elsevier Sciences 2002: 363-364.
26. Agarwal AK, Manvi KN, Mehta JM, et al. Clinical diagnosis of hepatoma. J Assoc Phys India 1966; 14: 465-468.
27. Okuda K, Nakashima T, Sakamoto K, et al. Hepatocellular carcinoma arising in noncirrhotic and highly cirrhotic livers; a comparative study of histopathology and frequency of hepatitis B markers. Cancer 1982; 49: 450-455.
28. Durga R, Muralikrishna P. Viral markers in hepatocellular carcinoma. Ind J Gastroenterol 1994; 13: A57.
29. Sundaram C, Reddy CRRM, Venkataramana G, et al. Hepatitis B surface antigen, hepatocellular carcinoma and cirrhosis in South India-an autopsy study. Indian J Pathol Microbiol 1990; 33: 334-338.
30. Prabhakar V, Rao KS, Reddy DJ. Primary carcinoma of liver in Vishakhapatnam. Ind J pathol Microbiol 1966; 9: 54-60.
31. Patil S, Bhuyan BK, Nanda BK. A study of ninety three cases of primary carcinoma of liver. Indian J Pathol Microbiol 1982; 25: 135-138.
32. Darwish MA, Faris R, Darwish N, et al. Hepatitis C and cirrhotic liver disease in the Nile Delta of Egypt: A community-based study. Am J Trop Med Hyg 2001; 64: 147-153.
33. Joshi N, Kumar A, Rani MS, et al. Clinical and aetiological profile of hepatoma at a tertiary care centre. Trop Gastroenterol 2003; 24: 73-75.
34. Wong PY, Xia V, Imagawa DK, Hoefs J, Hu KQ Clinical Presentation of Hepatocellular Carcinoma (HCC) in Asian Americans Versus Non-Asian-Americans. J Immigr Minor Health 2011; 13: 842-848.
35. Block TM, Mehta AS, Fimmel CJ et al. Molecular viral oncology of hepatocellular carcinoma. Oncogene 2003; 22: 5093-5107.
36. Anthony PP. Hepatocellular carcinoma: An overview. Histopathology 2001; 39: 109-118.
37. Hadziyannis S, Tabor E, Kaklamani E, et al. A case-control study of hepatitis B and C virus infections in the etiology of hepatocellular cardnoma. Int J Cancer 1995; 60: 627-631.
38. Vail Mayans M, Calvet X, Bruix J, et al. Risk factors for hepatocellular carcinoma in Catalonia, Spain. Int J Cancer 1990; 46: 378-381.
39. Paul SB, Sreenivas V, Gulati MS, et al. Incidence of hepatocellular carcinoma among Indian patients with cirrhosis of liver: An experience from a tertiary care center in northern India. Indian J Gastroenterol 2007; 26: 274-278.
40. Narahari S, Juwle A, Basak S, et al. Prevalence and geographic distribution of Hepatitis C Virus genotypes in Indian patient cohort. Infect Genet Evol 2009; 9: 643-645.
41. Chandra M, Thippavuzzula R, Ramachandra Rao VV, et al. Genotyping of Hepatitis C virus (HCV) in infected patients from South India. Infect Genet Evol 2007; 7: 724-730.
42. Chaudhuri S, Das S, Chowdhury A, et al. Molecular epidemiology of HCV infection among acute and chronic liver disease patients in Kolkata. India J Clin Virol 2005; 32: 38-46.
43. Singh S, Malhotra V, Sarin SK. Distribution of hepatitis C virus genotypes in patients with chronic hepatitis C infection in India. Indian J Med Res 2004; 119: 145-148.
44. Amarapurkar D, Dhorda M, Kirpalani A, et al. Prevalence of hepatitis C genotypes in Indian patients and their clinical significance. J Assoc Physicians India 2001; 49: 983-985.
45. Tanaka K, Hirohata T, Koga S, et al. Hepatitis C and hepatitis B in the etiology of hepatocellular carcinoma in the Japanese population. Cancer Res 1991; 51: 2842-2847.
46. Tsai JF, Chang WY, Jeng JE, et al. Hepatitis B and C virus infection as risk factors for liver cirrhosis and cirrhotic hepatocellular carcinoma: A case-control study. Liver 1994; 14: 98-102.
47. Zhang JY, Dai M, Wang X, et al. A case-control study of hepatitis B and C virus infection as risk factors for hepatocellular carcinoma in Henan China. Int J Epidemiol 1998; 27: 574-578.
48. Zhang JY. The research progress of the relationship between hepatitis B, C infection and hepatocellular carcinoma. In: Zhang JY, Zheng PY, Zhang Y, eds. Research and Practice in Viral Liver Diseases. Beijing: Chinese Science and Technology Press 1995; 148-1467.
49. Fong T-L, Lee SR, Briggs WK, et al. Clinical significance of hepatitis C viral RNA status and its correlation to antibodies to structural HCV antigens in anti-HCV reactive patients with normal liver tests. J Med Virol 1996; 49: 253-258.
50. Tsai JF, Chang WY, Jeng JE, et al. Effects of hepatitis C and B viruses infection on the development of hepatocellular carcinoma. J Med Virol 1994; 44: 92-95.
51. Di Bisceglie AM, Carithers RL Jr, Gores GJ. Hepatocellular carcinoma. Hepatology 1998; 28: 1161-1165.
52. Bosch FX, Ribes J, Diaz M, et al. Primary liver cancer: Worldwide incidence and trends. Gastroenterology 2004; 127: S5-S16.
53. Satapathy SK, Garg S, Chauhan R, et al. Profile of chronic hepatitis B virus in children in India: Experience with 116 children. J Gastroenterol Hepatol 2006; 21: 1170-1176.
54. Saini N, Bhagat A, Sharma S, et al. Evaluation of clinical and biochemical parameters in hepatocellular carcinoma: Experience from an Indian center. Clin Chim Acta. 2006; 371: 183-186.